News

• Merck to buy Pandion in $1.8 billion cash deal
  02/25/2021 / 12:57 - TeleTrader
•  
• Merck to appoint Robert Davis as new CEO
  02/04/2021 / 16:14 - TeleTrader
•  
• Merck sales rise 5% to $12.5B in Q4
  02/04/2021 / 12:50 - TeleTrader
•  
• Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient
  01/26/2021 / 14:00 - GlobeNewswire
•  
• Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement
  01/19/2021 / 14:00 - GlobeNewswire
•  
• Merck, US gov't sign COVID therapeutic supply deal
  12/23/2020 / 14:14 - TeleTrader
•  
• Merck divests direct holding in Moderna
  12/02/2020 / 13:19 - TeleTrader
•  
• Merck to buy COVID therapy candidate maker OncoImmune
  11/23/2020 / 13:09 - TeleTrader
•  
• An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
  11/10/2020 / 14:45 - GlobeNewswire
•  
• Merck revenue rises 1% YoY to $12.6B in Q3
  10/27/2020 / 11:56 - TeleTrader
•  
• Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  09/17/2020 / 14:00 - GlobeNewswire
•  
• PTA-News: 4SC AG: 4SC expands avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer<BR/>for further clinical combination study of domatinostat in Merkel cell carcinoma
  09/15/2020 / 07:30 - pressetext
•  
• NKMax America Announces a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer
  09/09/2020 / 01:00 - GlobeNewswire
•  
• Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
  08/06/2020 / 14:05 - GlobeNewswire
•  
• Merck EPS rise by 15% to $1.18 in Q2
  07/31/2020 / 12:51 - TeleTrader